Enova International stock saw its IBD SmartSelect Composite Rating jump to 96 Tuesday, up from 93 the day before.
Looking For The Best Stocks To Buy And Watch? Start Here
The new score indicates the company is now outperforming 96% of all stocks in terms of the most important fundamental and technical stock-picking criteria. History shows the top market performers tend to have a 95 or higher score as they launch their major moves.
Enova International Stock A Buy?
Enova International has been trading tightly along its 50- and 200-day moving average and is not currently near a proper entry. Look for the stock to form and break out of a new base.
The finance stock has a 93 EPS Rating, which means its recent quarterly and annual earnings growth tops 93% of all stocks.
Its Accumulation/Distribution Rating of C- shows a roughly equal amount of buying and selling by institutional investors over the last 13 weeks.
In Q1, the fintech company reported 56% earnings-per-share growth. Sales growth fell to 22%, down from 25% in the previous quarter.
Enova International stock holds the No. 2 rank among its peers in the Finance-Consumer Loans industry group. Atlanticus Holdings is the top-ranked stock within the group.
This article was created automatically with Stats Perform's Wordsmith software using data and article templates supplied by Investor's Business Daily. An IBD journalist may have edited the article.
